ReviewTherapeutic advances in ophthalmology

The role of KPI-121 0.25% in the treatment of dry eye disease: penetrating the mucus barrier to treat periodic flares.

Preeya K Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.